Search Results

There are 7080 results for: content related to: OnabotulinumtoxinA for the Treatment of Headache

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  2. An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 2, February 2014, Pages: 269–277, Roger Cady, Ira Turner, Kent Dexter, M. E. Beach, Ryan Cady and Paul Durham

    Version of Record online : 22 OCT 2013, DOI: 10.1111/head.12250

  3. You have free access to this content
    Botulinum toxin type A for the treatment of lower urinary tract disorders

    International Journal of Urology

    Volume 19, Issue 3, March 2012, Pages: 202–215, Teruhiko Yokoyama, Michael B Chancellor, Keiji Oguma, Yumiko Yamamoto, Tomonori Suzuki, Hiromi Kumon and Atsushi Nagai

    Version of Record online : 6 JAN 2012, DOI: 10.1111/j.1442-2042.2011.02946.x

  4. You have free access to this content
    Botulinum toxin injection for lower urinary tract dysfunction

    International Journal of Urology

    Volume 20, Issue 1, January 2013, Pages: 40–55, Yue-Chen Kuo and Hann-Chorng Kuo

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1442-2042.2012.03035.x

  5. Difficult Urination Does Not Affect the Successful Outcome after 100U OnabotulinumtoxinA Intravesical Injection in Patients with Idiopathic Detrusor Overactivity

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 1, January 2012, Pages: 29–34, Yih-Chou CHEN and Hann-Chorng KUO

    Version of Record online : 12 SEP 2011, DOI: 10.1111/j.1757-5672.2011.00102.x

  6. Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue S2, March 2015, Pages: 103–122, Richard B. Lipton and Stephen D. Silberstein

    Version of Record online : 6 FEB 2015, DOI: 10.1111/head.12505_2

  7. You have full text access to this OnlineOpen article
    Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 10, November/December 2014, Pages: 1565–1573, John F. Rothrock, Lisa M. Bloudek, Timothy T. Houle, Diane Andress-Rothrock and Sepideh F. Varon

    Version of Record online : 8 OCT 2014, DOI: 10.1111/head.12456

  8. You have free access to this content
    OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 6, June 2010, Pages: 921–936, David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener and Mitchell F. Brin

    Version of Record online : 7 MAY 2010, DOI: 10.1111/j.1526-4610.2010.01678.x

  9. Advances in the use of botulinum neurotoxins in facial esthetics

    Journal of Cosmetic Dermatology

    Volume 11, Issue 1, March 2012, Pages: 42–50, Timothy Corcoran Flynn

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1473-2165.2011.00593.x

  10. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 9, October 2011, Pages: 1358–1373, Sheena K. Aurora, Paul Winner, Marshall C. Freeman, Egilius L. Spierings, Jessica O. Heiring, Ronald E. DeGryse, Amanda M. VanDenburgh, Marissa E. Nolan and Catherine C. Turkel

    Version of Record online : 29 AUG 2011, DOI: 10.1111/j.1526-4610.2011.01990.x

  11. Scientific Programme 44th Annual Meeting of the International Continence Society (ICS) 20—24 October 2014, Rio de Janeiro, Brazil

    Neurourology and Urodynamics

    Volume 33, Issue 6, August 2014, Pages: 631–1071,

    Version of Record online : 7 JUL 2014, DOI: 10.1002/nau.22655

    Corrected by:

    Erratum: Erratum

    Vol. 34, Issue 8, 802, Version of Record online: 25 AUG 2015

  12. You have free access to this content
    A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue 10, November/December 2009, Pages: 1466–1478, Ninan T. Mathew and Sayyed Farhan A. Jaffri

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1526-4610.2009.01566.x

  13. Abstracts

    Neurourology and Urodynamics

    Volume 34, Issue S3, August 2015, Pages: S1–S461,

    Version of Record online : 5 JUL 2015, DOI: 10.1002/nau.22830

  14. Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome—A real-life practice of 290 cases in a single center

    Neurourology and Urodynamics

    Yuan-Hong Jiang, Hueih-Ling Ong and Hann-Chorng Kuo

    Version of Record online : 28 SEP 2015, DOI: 10.1002/nau.22892

  15. Abstracts

    Neurourology and Urodynamics

    Volume 35, Issue S4, August 2016, Pages: S1–S471,

    Version of Record online : 5 JUL 2016, DOI: 10.1002/nau.23074

  16. You have full text access to this OnlineOpen article
    OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

    Acta Neurologica Scandinavica

    Volume 129, Issue 1, January 2014, Pages: 61–70, S. K. Aurora, D. W. Dodick, H.-C. Diener, R. E. DeGryse, C. C. Turkel, R. B. Lipton and S. D. Silberstein

    Version of Record online : 20 SEP 2013, DOI: 10.1111/ane.12171

  17. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  18. The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: A systematic review and meta-analysis

    Neurourology and Urodynamics

    Volume 34, Issue 5, June 2015, Pages: 413–419, Yuanshan Cui, Xin Zhou, Huantao Zong, Huilei Yan and Yong Zhang

    Version of Record online : 28 MAR 2014, DOI: 10.1002/nau.22598

  19. The Therapeutic Effects of Repeated Detrusor Injections Between 200 or 300 Units of OnabotulinumtoxinA in Chronic Spinal Cord Injured Patients

    Neurourology and Urodynamics

    Volume 33, Issue 1, January 2014, Pages: 129–134, Yih-Chou Chen and Hann-Chorng Kuo

    Version of Record online : 12 MAR 2013, DOI: 10.1002/nau.22395

  20. Dose response with onabotulinumtoxinA for post-stroke spasticity: A pooled data analysis

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 209–215, Stuart A. Yablon, Mitchell F. Brin, Amanda M. VanDenburgh, Jihao Zhou, Susan M. Garabedian-Ruffalo, Susan Abu-Shakra and Frederick C. Beddingfield III

    Version of Record online : 19 OCT 2010, DOI: 10.1002/mds.23426